| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-05 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.0003 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0003 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0004 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |